JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB104667

Recombinant Human 4E-BP2 protein

Be the first to review this product! Submit a review

|

(1 Publication)

Recombinant Human 4E-BP2 protein is a Human Full Length protein, in the 1 to 120 aa range, expressed in Escherichia coli, with >85%, suitable for SDS-PAGE, Mass Spec.

View Alternative Names

Eukaryotic translation initiation factor 4E-binding protein 2, 4E-BP2, eIF4E-binding protein 2, EIF4EBP2

1 Images
SDS-PAGE - Recombinant Human 4E-BP2 protein (AB104667)
  • SDS-PAGE

Supplier Data

SDS-PAGE - Recombinant Human 4E-BP2 protein (AB104667)

SDS-PAGE of ab104667 (3?g) under reducing condition and visualized by coomassie blue stain.

Key facts

Purity

>85% SDS-PAGE

Expression system

Escherichia coli

Tags

His tag N-Terminus

Applications

SDS-PAGE, Mass Spec

applications

Biologically active

No

Accession

Q13542

Animal free

No

Carrier free

No

Species

Human

Storage buffer

pH: 8 Constituents: 10% Glycerol (glycerin, glycerine), 0.58% Sodium chloride, 0.316% Tris HCl, 0.0154% (R*,R*)-1,4-Dimercaptobutan-2,3-diol

storage-buffer

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "SDS-PAGE": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "Mass Spec": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Sequence info

[{"sequence":"MGSSHHHHHHSSGLVPRGSHMSSSAGSGHQPSQSRAIPTRTVAISDAAQLPHDYCTTPGGTLFSTTPGGTRIIYDRKFLLDRRNSPMAQTPPCHLPNIPGVTSPGTLIEDSKVEVNNLNNLNNHDRKHAVGDDAQFEMDI","proteinLength":"Full Length","predictedMolecularWeight":"15.1 kDa","actualMolecularWeight":null,"aminoAcidEnd":120,"aminoAcidStart":1,"nature":"Recombinant","expressionSystem":"Escherichia coli","accessionNumber":"Q13542","tags":[{"tag":"His","terminus":"N-Terminus"}]}]

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle
False

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The 4E-BP2 protein also known as eukaryotic translation initiation factor 4E-binding protein 2 is an important regulator of translation initiation. It is a small protein with a molecular weight of approximately 14 kDa. 4E-BP2 is expressed in various tissues with a prominent presence in the brain. This protein binds to eukaryotic initiation factor 4E (eIF4E) inhibiting the initiation of cap-dependent translation by preventing eIF4E from assembling into the larger eIF4F complex.
Biological function summary

The 4E-BP2 protein inhibits the initiation of protein synthesis regulating gene expression at a translational level. 4E-BP2 does not form part of a stable complex but transiently interacts with eIF4E in response to different cellular signals. When 4E-BP2 is phosphorylated by mammalian target of rapamycin (mTOR) it undergoes a conformational change that weakens its binding to eIF4E allowing protein synthesis to proceed. This regulation exhibits tissue specificity and involves responses to growth factors nutrients and cellular stress.

Pathways

The involvement of 4E-BP2 is important in the mTOR signaling pathway a central pathway regulating cell growth and metabolism in response to environmental cues. The mTOR pathway includes other proteins like eIF4E which 4E-BP2 interacts with directly and mTOR itself which phosphorylates 4E-BP2. Additionally 4E-BP2 also participates in the insulin signaling pathway influencing how cells respond to insulin and other growth factors by regulating protein translation.

Altered 4E-BP2 function has implications in neurological disorders and cancer. In the brain dysregulation of 4E-BP2 is associated with autism spectrum disorders as its role in neural development and plasticity is important. In cancer aberrant activity of 4E-BP2 can lead to unchecked cellular proliferation due to disrupted control of protein synthesis. The protein's regulation by mTOR links it to various cancers as increased mTOR activity can result in decreased 4E-BP2 activity facilitating tumorigenesis.

Specifications

Form

Liquid

Additional notes

purified by using anion-exchange chromatography (DEAE sepharose resin) and gel-filtration chromatography (Sephacryl S-200) with 20mM Tris pH 7.5, 2mM EDTA.

General info

Function

Repressor of translation initiation involved in synaptic plasticity, learning and memory formation (PubMed : 30765518). Regulates EIF4E activity by preventing its assembly into the eIF4F complex : hypophosphorylated form of EIF4EBP2 competes with EIF4G1/EIF4G3 and strongly binds to EIF4E, leading to repress translation. In contrast, hyperphosphorylated form dissociates from EIF4E, allowing interaction between EIF4G1/EIF4G3 and EIF4E, leading to initiation of translation (PubMed : 25533957, PubMed : 30765518). EIF4EBP2 is enriched in brain and acts as a regulator of synapse activity and neuronal stem cell renewal via its ability to repress translation initiation (By similarity). Mediates the regulation of protein translation by hormones, growth factors and other stimuli that signal through the MAP kinase and mTORC1 pathways (By similarity).

Sequence similarities

Belongs to the eIF4E-binding protein family.

Post-translational modifications

Phosphorylation at Thr-37, Thr-46, Ser-65, Thr-70 and Ser-83 is mediated by MTOR and corresponds to the hyperphosphorylated form: it abolishes binding to EIF4E by inducing folding of intrinsically disordered regions (PubMed:24207126, PubMed:25533957). First phosphorylated at Thr-37 and Thr-46 by MTOR, inducing folding of region encompassing residues from Pro-18 to Arg-62 of into a four-stranded beta-domain that sequesters the helical YXXXXLPhi motif into a partly buried beta-strand, blocking accessibility to EIF4E. Protein phosphorylated at Thr-37 and Thr-46 is however unstable and subsequent phosphorylation at Ser-65, Thr-70 and Ser-83 is required to stabilize the fold, decreasing affinity for EIF4E by a factor of 4000 (PubMed:24207126, PubMed:25533957). Phosphorylated in response to insulin, EGF and PDGF.. Deamidated at Asn-99 and Asn-102 to aspartate (Asp) in brain. Deamidation promotes interaction with RPTOR, subsequent phosphorylation by mTORC1 and increased translation, leading to impair kinetics of excitatory synaptic transmission. Deamidation takes place during postnatal development, when the PI3K-Akt-mTOR signaling is reduced, suggesting it acts as a compensatory mechanism to promote translation despite attenuated PI3K-Akt-mTOR signaling in neuron development. Deamidation converts Asn residues into a mixture of Asp and isoaspartate; interactions with PCMT1 is required to prevent isoaspartate accumulation and convert isoaspartate to Asp.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Repressor of translation initiation involved in synaptic plasticity, learning and memory formation (PubMed : 30765518). Regulates EIF4E activity by preventing its assembly into the eIF4F complex : hypophosphorylated form of EIF4EBP2 competes with EIF4G1/EIF4G3 and strongly binds to EIF4E, leading to repress translation. In contrast, hyperphosphorylated form dissociates from EIF4E, allowing interaction between EIF4G1/EIF4G3 and EIF4E, leading to initiation of translation (PubMed : 25533957, PubMed : 30765518). EIF4EBP2 is enriched in brain and acts as a regulator of synapse activity and neuronal stem cell renewal via its ability to repress translation initiation (By similarity). Mediates the regulation of protein translation by hormones, growth factors and other stimuli that signal through the MAP kinase and mTORC1 pathways (By similarity).
See full target information Eukaryotic translation initiation factor 4E-binding protein 2

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

Molecular reproduction and development 79:767-76 PubMed22968905

2012

The eIF4E repressor protein 4E-BP2 is merely truncated, despite 4E-BP1 degradation in the porcine uterine tissue during implantation.

Applications

Unspecified application

Species

Unspecified reactive species

Karin Wollenhaupt,Klaus-Peter Brüssow,Dirk Albrecht,Wolfgang Tomek
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Associated Products

Select an associated product type
Alternative Product
Proteins & Peptides

AB172157

Recombinant Human 4E-BP2 protein

proteins-peptides

recombinant-human-4e-bp2-protein-ab172157

0

(0 reviews)

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com